APOTEKEREN A.M.B.A. — Credit Rating and Financial Key Figures
CVR number: 16938106
Fruebjergvej 3, 2100 København Ø
apotekeren@apotekerenamba.dk
tel: 70201489
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 62 830.00 | 66 162.00 | 71 658.00 | 70 097.00 | 78 436.01 |
Employee benefit expenses | -7 804.00 | -8 475.00 | -8 336.00 | -8 719.00 | -8 944.26 |
Other operating expenses | -8.00 | ||||
Total depreciation | -10.00 | -71.90 | |||
EBIT | 55 008.00 | 57 687.00 | 63 322.00 | 61 378.00 | 69 419.84 |
Other financial income | 2.00 | 5.00 | 5.00 | 9.00 | 131.94 |
Other financial expenses | - 121.00 | - 195.00 | - 239.00 | - 286.00 | -66.30 |
Net income from associates (fin.) | 16.00 | 9.00 | |||
Pre-tax profit | 54 889.00 | 57 513.00 | 63 097.00 | 61 101.00 | 69 485.48 |
Income taxes | -1.00 | 1.00 | -0.32 | ||
Net earnings | 54 889.00 | 57 512.00 | 63 098.00 | 61 101.00 | 69 485.17 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 799.79 | ||||
Tangible assets total | 799.79 | ||||
Participating interests | 737.00 | 770.00 | 833.00 | 790.83 | |
Other receivables | 238.00 | 238.00 | 238.00 | 238.00 | 237.81 |
Investments total | 238.00 | 975.00 | 1 008.00 | 1 071.00 | 1 028.64 |
Non-current loans receivable | 629.00 | ||||
Long term receivables total | 629.00 | ||||
Inventories total | |||||
Current trade debtors | 16 791.00 | 21 186.00 | 18 394.00 | 15 349.00 | 20 791.75 |
Current amounts owed by group member comp. | 500.00 | 250.00 | |||
Current owed by particip. interest comp. | 225.00 | 694.00 | |||
Prepayments and accrued income | 734.00 | 602.00 | 702.00 | 2 147.00 | 862.86 |
Current other receivables | 2 589.00 | 2 765.00 | 3 481.00 | 2 565.00 | 5 756.18 |
Short term receivables total | 20 114.00 | 24 778.00 | 23 271.00 | 20 561.00 | 27 660.79 |
Cash and bank deposits | 19 456.00 | 16 531.00 | 23 279.00 | 22 246.00 | 21 968.59 |
Cash and cash equivalents | 19 456.00 | 16 531.00 | 23 279.00 | 22 246.00 | 21 968.59 |
Balance sheet total (assets) | 40 437.00 | 42 284.00 | 47 558.00 | 43 878.00 | 51 457.81 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 88.00 | 85.00 | 83.00 | 78.00 | 77.00 |
Shares repurchased | 37 070.00 | 38 460.00 | 45 550.00 | 61 000.00 | 69 449.80 |
Other reserves | -19 000.00 | -20 249.80 | |||
Retained earnings | -54 883.00 | -57 458.00 | -63 000.00 | -60 905.00 | -69 268.83 |
Profit of the financial year | 54 889.00 | 57 512.00 | 63 098.00 | 61 101.00 | 69 485.17 |
Shareholders equity total | 37 164.00 | 38 599.00 | 45 731.00 | 42 274.00 | 49 493.33 |
Non-current liabilities total | |||||
Current trade creditors | 2 202.00 | 1 547.00 | 928.00 | 884.00 | 961.26 |
Current owed to participating | 31.00 | 12.00 | 9.00 | 23.03 | |
Short-term deferred tax liabilities | 1.00 | 0.32 | |||
Other non-interest bearing current liabilities | 1 071.00 | 2 106.00 | 887.00 | 711.00 | 979.87 |
Current liabilities total | 3 273.00 | 3 685.00 | 1 827.00 | 1 604.00 | 1 964.47 |
Balance sheet total (liabilities) | 40 437.00 | 42 284.00 | 47 558.00 | 43 878.00 | 51 457.81 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.